Literature DB >> 6802759

Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation.

R R Arnold, J E Russell, W J Champion, M Brewer, J J Gauthier.   

Abstract

Previous studies have demonstrated a direct iron-irreversible inhibition of a variety of microorganisms by human apolactoferrin. The present study compared the bactericidal effects of lactoferrin on Streptococcus mutans with the bacteriostatic effects of iron deprivation. Growth (as determined by change in optical density) and macromolecular synthesis, as determined by incorporation of (14)C-labeled uracil, thymidine, and lysine, were inhibited by incubation of washed exponential-phase S. mutans NCTC 10449 with purified human apolactoferrin. Similarly, apolactoferrin inhibited glucose uptake and metabolism. Iron-saturated lactoferrin had no effect on bacterial growth or metabolism and was capable of serving as a source of iron in iron-depleted medium. S. mutans failed to grow, and there was no indication of macromolecular synthesis in iron-depleted partially defined medium; however, glucose metabolism continued, though at a reduced rate, and viability was retained for 72 h. There was no detectable metabolism of glucose by cells maintained for 18 h in iron-free medium. Metabolism was restored by transfer of iron-depleted S. mutans to iron-complete medium. This was in contrast to the irreversible inhibition by lactoferrin after 1 h of incubation. Inhibition could not be reversed by removal of cell surface-associated lactoferrin as detected by rhodamine isothiocyanate-labeled antilactoferrin. This inhibition of metabolism and rapid loss in viability observed with lactoferrin treatment suggest that lactoferrin has a direct bactericidal effect on S. mutans that cannot be attributed to simple iron deprivation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802759      PMCID: PMC351118          DOI: 10.1128/iai.35.3.792-799.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Siderophore production by Vibrio cholerae.

Authors:  S M Payne; R A Finkelstein
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

2.  Effect of pH and haem compounds on the killing of Pasteurella septica by specific antiserum.

Authors:  E Griffiths
Journal:  J Gen Microbiol       Date:  1975-06

Review 3.  Role of iron in bacterial infection.

Authors:  J J Bullen; H J Rogers; E Griffiths
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

4.  A bactericidal effect for human lactoferrin.

Authors:  R R Arnold; M F Cole; J R McGhee
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

Review 5.  Iron and susceptibility to infectious disease.

Authors:  E D Weinberg
Journal:  Science       Date:  1974-05-31       Impact factor: 47.728

6.  Association of lactoferrin with lysozyme in granules of human polymorphonuclear leukocytes.

Authors:  M S Leffell; J K Spitznagel
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

7.  Mechanism of action of specific antiserum on Pasteurella septica. Selective inhibition of net macromolecular synthesis and its reversal by iron compounds.

Authors:  E Griffiths
Journal:  Eur J Biochem       Date:  1971-11-11

8.  Selective inhibition of macromolecular synthesis in Pasteurella septica by antiserum and its reversal by iron.

Authors:  E Griffiths
Journal:  Nat New Biol       Date:  1971-07-21

9.  The role of lactoferrin in the bactericidal function of polymorphonuclear leucocytes.

Authors:  J J Bullen; J A Armstrong
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

10.  Lactoferrin, an iron-binding protein in neutrophilic leukocytes.

Authors:  P L Masson; J F Heremans; E Schonne
Journal:  J Exp Med       Date:  1969-09-01       Impact factor: 14.307

View more
  53 in total

Review 1.  Antimicrobial polypeptides in host defense of the respiratory tract.

Authors:  Tomas Ganz
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Diane Dryja; Allen Leavens; Ronald L Neiswander; Haiping Qiao; Douglas DiRienzo; Pearay Ogra
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

3.  In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Haiping Qiao; Diane Dryja; Allen Leavens; Jon Rossman; Gary Rich; Douglas Dirienzo; Pearay L Ogra
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

4.  PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].

Authors:  Mirza Shaper; Susan K Hollingshead; William H Benjamin; David E Briles
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

5.  Effects of a composition containing lactoferrin and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, crossover, placebo-controlled clinical trial.

Authors:  Kouichirou Shin; Ken Yaegaki; Takatoshi Murata; Hisataka Ii; Tomoko Tanaka; Izumi Aoyama; Koji Yamauchi; Tomohiro Toida; Keiji Iwatsuki
Journal:  Clin Oral Investig       Date:  2010-05-29       Impact factor: 3.573

6.  Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.

Authors:  Shaper Mirza; Landon Wilson; William H Benjamin; Jan Novak; Stephen Barnes; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

Review 7.  Biological role of lactoferrin.

Authors:  L Sánchez; M Calvo; J H Brock
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

8.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

9.  Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.

Authors:  D Caccavo; A Afeltra; S Pece; G Giuliani; M Freudenberg; C Galanos; E Jirillo
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

10.  Calcium-binding properties of SSP-5, the Streptococcus gordonii M5 receptor for salivary agglutinin.

Authors:  Y Duan; E Fisher; D Malamud; E Golub; D R Demuth
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.